We are proud to announce the release of new scientific publication at the Journal of Cancer Research and Clinical Oncology on Protectival’s (clinical name: LCS101)  synergistic effect with radiotherapy.

From the publication:

The addition of the botanical formula LCS101 to irradiated cancer cells results in an apparent additive effect, most likely through a ROS-mediated mechanism. These findings support the use of LCS101 by patients undergoing radiation therapy, for both its clinical as well as anti-cancer effects.

Click here for the full publication. 

More from our Blog

7 Tips To Help Build Your Immune System

7 Tips To Help Build Your Immune System

While a big part of the world is under lock down and instructed for all the right reasons to keep distance and maintain good hygiene in order to slow down the spread of the coronavirus, there is very little said about how we can prepare our body to be better...

read more
Introducing LifeBiotic’s New Immunity Packs

Introducing LifeBiotic’s New Immunity Packs

Immunity is our first line of defence. The latest outbreak has been shown to have a stronger effect on those with compromised immune systems, including older people and those with existing health conditions.  LifeBiotic’s Immune Packs include Protectival and Tonix-R,...

read more
JoinLifeBiotic's Newsletter

JoinLifeBiotic's Newsletter

 

Receive the latest news, updates and offers from our team.

You have Successfully Subscribed!

Share This
0